Back to top
more

First Trust NYSE Arca Biotechnology ETF: (FBT)

(Delayed Data from NYSE) As of Aug 23, 2024 03:56 PM ET

$170.94 USD

170.94
15,088

+1.36 (0.80%)

Volume: 15,088

Zacks ETF Rank

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

2 - Buy of 5   2      

After-Market: $170.83 -0.11 (-0.06 %) 7:58 PM ET

Zacks News

Sweta Jaiswal, FRM headshot

Will Biotech ETFs Continue to Rally in Q1 Earnings?

Here we study the possible impact of some major Q1 earnings releases on certain biotech ETFs .

Sanghamitra Saha headshot

Health Day Checkup of Medical ETFs: 5 Top Picks

M&A activity, approval of novel drugs and earnings growth in Q1 put healthcare ETFs in a decent spot.

Neena Mishra headshot

Top-Performing ETFs Of The 10-Year Bull-Run

Learn more about the ETFs that crushed the broad indexes during the ten-year bull-run.

Sweta Killa headshot

10 Top-Ranked ETFs Leading the 10-Year Bull Run

We have presented a bunch of top-performing ETFs of the 10-year bull market that will continue to outperform in the coming months given that these have a Zacks ETF Rank #1 (Strong Buy) or 2 (Buy).

Sanghamitra Saha headshot

4 Sector ETFs That Crushed S&P 500 in Decade-Old Bull Run

These sector ETFs emerged winners in the 10-year old bull market.

Sanghamitra Saha headshot

Despite M&A Spree, Biotech ETFs Slide on Mixed Earnings

Biotech stocks came up with mixed earnings and weighed on the related ETFs in the key reporting season.

Sanghamitra Saha headshot

What's Behind the Biotech ETF Rally to Start 2019?

Biotech ETFs have been riding on the wave of mergers and acquisitions as well as drug approvals.

Biotech ETFs in Focus on String of Q3 Earnings Beat

Biotech ETFs draw attention post impressive Q3 results.

5 Health Care ETFs Outperforming XLV on YTD Basis

Health care ETFs provide handsome returns year to date.

    Sanghamitra Saha headshot

    4 Sector ETFs That Crushed S&P 500 in Longest Bull Market

    These sector ETFs outperformed the S&P 500 in the longest-ever bull market.

      Sweta Killa headshot

      Market-Beating, Top-Ranked ETFs of the Longest Bull Market

      The U.S. bull market is now the longest ever, stretching 3,453 days or nine and-a-half years. We have presented a bunch of top performing ETFs of the longest bull market.

        Sanghamitra Saha headshot

        Biotech ETFs in Focus on String of Q2 Earnings Beat

        Biotech ETFs draw attention post impressive Q2 results.

          Neena Mishra headshot

          What Investors Need to Know about Biotech ETFs

          Smaller biotech stocks are outperforming this year; learn more about biotech ETFs best positioned to benefit

            Sweta Killa headshot

            5 Safe and Sound ETF Strategies for 2H

            After a bumpy ride in the first half of the year, global stocks are bouncing back despite the trade war fears.

              Sweta Killa headshot

              Biotech ETFs Surge on Biogen's Positive Drug Trial Result

              Biotech ETFs surge on Biogen's encouraging Phase 2 clinical study data for Alzheimer???s treatment.

                Sweta Killa headshot

                4 Hot Sector ETFs Springing Up to Rank #1

                A number of funds in their respective sectors have seen their Ranks surging to the top hierarchy and could make great spring picks.

                  Sweta Killa headshot

                  M&A Waves Pushing Biotech ETFs Higher

                  The new tax legislation has enticed U.S. companies to bring offshore cash back home, sparking waves of mergers and acquisitions.

                    Biotech ETFs: What Lies Ahead?

                    It's been a good year for biotech ETFs, can the rally continue?

                      The Zacks Analyst Blog Highlights: SPDR Technology ETF, SPDR S&P Biotech ETF, First Trust NYSE Arca Biotechnology Index Fund, BioShares Biotechnology Products ETF and SPDR Healthcare ETF

                      The Zacks Analyst Blog Highlights: SPDR Technology ETF, SPDR S&P Biotech ETF, First Trust NYSE Arca Biotechnology Index Fund, BioShares Biotechnology Products ETF and SPDR Healthcare ETF

                        Sweta Killa headshot

                        Trump Wins Healthcare Vote: ETFs to Watch

                        The bill is expected to cut billions of dollars in health-care spending and result in millions of Americans going without health insurance.

                          Time to Buy Biotech ETFs?

                          After a painful 2016, biotech stocks are recovering this year. What lies ahead?

                            What Lies Ahead for Biotech ETFs in Trump Era?

                            Despite political risks, there are many factors supporting growth in the biotech sector.